Lexamed GmbH: EU-GMP Medical Cannabis Excellence
Established in 2017, Lexamed GmbH has emerged as a leading player in the European medical cannabis market. As the exclusive importer for Germany & Poland of the renowned Green House Seed Co & Strain Hunters brands, we deliver premium EU-GMP certified medical cannabis products that meet the stringent quality standards and regulatory requirements of the German pharmaceutical industry. Our commitment to excellence, pharmaceutical-grade production processes, and strategic partnerships position us at the forefront of the rapidly evolving medical cannabis landscape in Europe.
Vision & Mission
Our Vision
Set the European benchmark for premium quality, safe and science-backed cannabis
Our Mission
Unite award-winning genetics, industrial-scale cultivation and German regulatory rigour to deliver consistent, high-quality medicine
Licences & Regulatory Standing
EU-GMP Manufacturer & Import Authorisation
No. DE_BW_01_MIA_2019_0039 (issued 09 May 2019)
Scope: cannabis flowers & extracts in oily solution (import, batch release, QC)
Wholesale Capabilities
Wholesale (GDP) + § 3 BtMG licence
Covers distribution of narcotics & psychotropics across Germany/EU
Regulatory Advantage
Combined EU-GMP + BtMG approvals create a high regulatory moat
Operations & Supply Chain
Cultivation
100-hectare indoor/greenhouse estate, Green House Energrow, Thailand
Processing
Primary packaging in Thailand → secondary packaging & batch-release in Karlsruhe
Distribution
GDP hubs at Komtur Pharma (Freiburg) & Namaste Europe (Burscheid)
Clinical Services
In-house medical practice planned for Q4-2025 (pain & oncology focus)
Product Portfolio
EU-GMP Premium dried flower in 10 gram containers
THC-dominant & balanced chemovars (10 g )
EU-GMP Premium dried flower
500 - 1000 grams bags
THC-dominant & balanced chemovars
Isolated cannabinoid APIs
THC, CBD, CBN in development
Future SKUs
vapes & capsules based on market feedback
Strategic Partnerships & Differentiators

Exclusive Green House genetics for DE & PL
Award-winning strains
Vertically-integrated 100 ha Thai supply
Ensures volume & consistency
Dual EU-GMP + BtMG licences
Rare among German start-ups
First Green House Energrow imports land in Germany 2025
ISO 9001 overlay and solar-powered cultivation
Strengthen ESG credentials
Milestones
1
2017
Company founded; German wholesale licence obtained
2
2019
EU-GMP manufacturer & import authorisation granted
3
2023
100 ha Thai site completed; Green House partnership signed
4
2024
Inaugural import batches pre-sold to German pharmacies
5
2025
Import & batch-release first Green House Energrow lots
6
2026
Begin regular supply to German & Polish pharmacy network
ESG & Compliance
Our comprehensive approach to environmental, social, and governance standards:
Quality
EU-GMP standards govern every step from cultivation to batch release.
Environment
Thai cultivation site uses solar-powered irrigation; CO₂ footprint < 60 g CO₂e per g dried flower (internal LCA).
Governance
Independent advisory board
Contact Us
Reach out to our team for inquiries about our EU-GMP medical cannabis products and services. We welcome partnerships and collaboration opportunities in the German and European markets.
Headquarters
Lexamed GmbH
Thujaweg 1
76149 Karlsruhe
Germany
Contact Details
Tel: +49 76 576 70 00
E-mail: info@lexamed-group.de
Online
Website: www.lexamed-group.de
Follow us on LinkedIn for industry updates
Our team of cannabis medicine specialists is available to discuss our product portfolio, EU-GMP certifications, and distribution opportunities throughout Europe.